Tenderwize
Back to tender search

Open-house rebate agreement for Aflibercept (excluding 114.3 mg/ml)

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Nov 03, 2027 · 444 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Aflibercept, ausgenommen 114,3 mg/ml, ATC S01LA05

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

The notice uses an open-house model while the form type is 'open'; although the buyer explains this, the procedural fra...

Paper submissions are only timely if the scan is sent in advance and the original paper documents arrive by the 10th of...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Dec 2027
  • Non-exclusive rebate agreements for the medicinal product Aflibercept, excluding 114.3 mg/ml, ATC S01LA05.
  • Supply contract for pharmaceutical products under an open-house model.
Show full summary

This is an open-house pharmaceutical supply arrangement by AOK Bayern for Aflibercept (excluding 114.3 mg/ml, ATC S01LA05). It is not a competitive award procedure in the usual sense: the buyer states that any pharmaceutical company meeting the stated suitability requirement can join on identical, non-negotiable terms. The contract period runs from 2026-01-01 to 2027-12-31, with contract entry possible until 2027-11-03. Submission is via DTVP electronic portal with qualified electronic signature or by signed paper originals in duplicate. No contract value is stated.

Risks

The notice uses an open-house model while the form type is 'open'; although the buyer explains this, the procedural fra...

Paper submissions are only timely if the scan is sent in advance and the original paper documents arrive by the 10th of...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Aflibercept (excluding 114.3 mg/ml)

Open-house supply arrangement for pharmaceutical rebate agreements concerning Aflibercept, excluding 114.3 mg/ml, ATC S01LA05. The lot is described as a non-exclusive, identical, non-individually negotiable contract offered to all interested pharmaceutical companies meeting the suitability requirement. Source: structured data and notice text.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Dec 2025 - Dec 2027

Category

Pharmaceutical products

Deadline

Deadline Nov 03, 2027

Procurement Details

Publication date
16 Nov 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
760140-2025

Documents (2)

Similar tenders